2015 to 2018 Hypertension Prevalence Nearly 50 Percent in the United States
By Elana Gotkine HealthDay Reporter
TUESDAY, Nov. 21, 2023 -- The prevalence of stage 1 and stage 2 hypertension in 2015 to 2018 was 44.2 percent in Los Angeles (LA) County and 47.3 percent in the United States, according to a report published in the November Health E-Stats, a publication of the U.S. Centers for Disease Control and Prevention National Center for Health Statistics.
Cheryl D. Fryar, M.S.P.H., from the National Center for Health Statistics in Hyattsville, Maryland, and colleagues present the percentage of adults in LA County and the United States with stage 1 and 2 hypertension, defined according to the 2017 blood pressure cut points (systolic blood pressure ≥130 mm Hg or diastolic blood pressure ≥80 mm Hg) or currently taking blood pressure medication during 2015 to 2018.
The researchers found that for adults ages 18 years and older, the unadjusted prevalence of hypertension (stage 1 and 2) was 44.2 and 47.3 percent in LA County and the United States, respectively; after adjustment for age, the prevalence was 43.3 and 44.5 percent, respectively. The unadjusted prevalence in women was 38.4 and 44.2 percent in LA County and the United States, respectively, while in men, the corresponding prevalence was 50.4 and 50.6 percent.
The prevalence of stage 2 hypertension in LA County and the United States was 30.4 and 33.0 percent, respectively. Of those with stage 2 hypertension, 68.4 and 71.2 percent of adults in LA County and the United States, respectively, received treatment, and the prevalence of controlled hypertension was 36.5 and 46.1 percent, respectively.
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
© 2024 HealthDay. All rights reserved.
Posted November 2023
Read this next
Blood Pressure Down With Self-Monitoring of BP, Self-Titration of Medications
FRIDAY, May 10, 2024 -- Blood pressure (BP) self-monitoring, together with self-titration of antihypertensive medications, is associated with a reduction in BP, according to a...
Novel Genetic Loci ID'd for Hypertension in European Ancestry
TUESDAY, May 7, 2024 -- A total of 113 novel genetic loci have been identified in the largest single-stage common variant genome-wide association study of blood pressure (BP)...
Long-Term Risk for MACE Increased for Children With Hypertension
TUESDAY, May 7, 2024 -- The long-term risk for major adverse cardiac events (MACE) is increased for children diagnosed with hypertension, according to a study published online May...
More news resources
- FDA Medwatch Drug Alerts
- Daily MedNews
- News for Health Professionals
- New Drug Approvals
- New Drug Applications
- Drug Shortages
- Clinical Trial Results
- Generic Drug Approvals
Subscribe to our newsletter
Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.